First Capital Inc: Form 10-Q for the period ended Sep 30, 2025
Filed with the SEC on Nov 14, 2025 and accepted by EDGAR at Nov 14, 2025, 16:32 ET.
Management's discussion and analysis
As filed, 1,412 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
| Period | | (a) Total Number of Shares Purchased | | (b) Average Price Paid Per Share | | (c) Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs | | (d) Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs |
|---|---|---|---|---|---|---|---|---|
| July 1 through July 31, 2025 | 235 | $43.76 | 235 | 113,236 | ||||
| | | | | | | | | |
| August 1 through August 31, 2025 | — | | N/A | — | 113,236 | |||
| | | | | | | | | |
| September 1 through September 30, 2025 | 1,208 | | 43.50 | 1,208 | 112,028 | |||
| | | | | | | | | |
| Total | 1,443 | | $43.55 | 1,443 |
On August 29, 2025, the Company entered into a Joint Rule 10b5-1/Rule 10b-18 Plan Agreement (the “Plan”) under which the Company’s designated broker has the authority to repurchase up to 113,236 shares of common stock of the Company. The Plan commenced on September 4, 2025, and expires on August 28, 2026. The Plan was established in connection with the Company’s previously disclosed stock repurchase authorization, which was approved by the Company’s Board of Directors on August 19, 2008. The purchases disclosed in the table above were made pursuant to the terms of the Plan.
Risk factors
As filed, 422 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
There have been no material changes to the risk factors previously disclosed in the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the year ended December 31, 2024.
Recent changes in international trade regulation or foreign trade policy, including tariffs, could lead to higher than anticipated inflation and supply chain disruption, which may impact consumer and commercial borrower performance.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2025-07-01 to 2025-09-30 | $1.9m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Revenue | 9 months2025-01-01 to 2025-09-30 | $5.3m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Operating income | 3 months2025-07-01 to 2025-09-30 | $5.5m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2025-01-01 to 2025-09-30 | $14.1m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2025-07-01 to 2025-09-30 | $1.1m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2025-01-01 to 2025-09-30 | $2.6m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2025-07-01 to 2025-09-30 | $4.5m | us-gaap:NetIncomeLoss |
| Net income | 9 months2025-01-01 to 2025-09-30 | $11.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2025-07-01 to 2025-09-30 | $1.34 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2025-01-01 to 2025-09-30 | $3.43 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2025-07-01 to 2025-09-30 | $1.34 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2025-01-01 to 2025-09-30 | $3.43 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2025-07-01 to 2025-09-30 | 3,350,008,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2025-01-01 to 2025-09-30 | 3,349,321,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2025-01-01 to 2025-09-30 | $16.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2025-01-01 to 2025-09-30 | $654.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2025-01-01 to 2025-09-30 | $3.0m | us-gaap:PaymentsOfDividends |
| Share repurchases | 9 months2025-01-01 to 2025-09-30 | $61.0k | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Total assets | At period end2025-09-30 | $1.24bn | us-gaap:Assets |
| Total liabilities | At period end2025-09-30 | $1.10bn | us-gaap:Liabilities |
| Short-term borrowings | At period end2025-09-30 | $0 | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2025-09-30 | $132.4m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001104659-25-112606. Last ingested by Listed: Nov 6, 2026, 18:07 ET. Listed shows no prices and gives no investment advice.